112 results
8-K
EX-99.1
BIOCQ
Biocept Inc
22 Aug 23
Biocept Reports Second Quarter 2023 Financial Results
4:10pm
.
Research and development (R&D) expenses for the second quarter of 2023 were $0.4 million, compared with $1.7 million for the second quarter of 2022 … and expenses:
Cost of revenues
Research and development expenses
General and administrative expenses
Sales and marketing expenses
Total costs
8-K
EX-99.1
BIOCQ
Biocept Inc
15 May 23
Biocept Reports First Quarter 2023 Financial Results
6:07am
of 2022, with the decrease primarily associated with the cessation of COVID-19 testing services.
Research and development expenses for the first quarter … and per share data)
(Unaudited)
For the Three Months Ended March 31,
Net revenues
Costs and expenses:
Cost of revenues
Research and development expenses
8-K
EX-99.1
iee8ggekgpez2jjsjh
17 Apr 23
Biocept Reports 2022 Financial Results
4:46pm
8-K
EX-99.1
oby0r3 d28i
21 Nov 22
Biocept Reports Third Quarter 2022 Financial Results
4:31pm
8-K
EX-99.1
zxodd1k4fnbv9din7d
14 Nov 22
Biocept Reports Second Quarter 2022 Financial Results
8:01am
8-K
EX-99.1
ajy 8smm3tu9
24 May 22
Biocept Reports First Quarter 2022 Financial Results
4:01pm
8-K
EX-99.1
p933vg
7 Apr 22
Biocept Reports 2021 Fourth Quarter and Full Year Financial Results
6:05am
8-K
raonqxd
16 Feb 22
Departure of Directors or Certain Officers
4:21pm